Takeda Pharmaceutical (TAK) Cash from Operations (2018 - 2026)
Takeda Pharmaceutical (TAK) recorded Cash from Operations of $800.69 million in the quarter ended Jun 30, 2026, down 46.2% from $1.49 billion a year earlier and down 41.7% from the prior quarter.
Powered by 
Analysis
Takeda Pharmaceutical (TAK) Cash from Operations (2018 - 2026) Analysis & Trends
On a TTM basis, Takeda Pharmaceutical's Cash from Operations came in at $11.16 billion as of Jun 30, 2026, up 1.3% year-over-year; for the year ended Mar 31, 2026, it was $6.92 billion, down 0.3% from the prior year.
- Annual Cash from Operations has a five-year compound annual growth rate of -6.2% (years ended Mar 2021 to Mar 2026).
- Across earlier years, Cash from Operations came in at $6.94 billion in the year ended Mar 31, 2025 (+39.7%), $4.97 billion in the year ended Mar 31, 2024 (-31.3%), $7.23 billion in the year ended Mar 31, 2023 (-27.7%) and $10 billion in the year ended Mar 31, 2022 (+4.9%).
- The figure for the quarter ended Jun 30, 2026 is the lowest quarterly Cash from Operations since the quarter ended Jun 30, 2023.
- On a year-over-year basis, Cash from Operations has declined for three consecutive quarters, with growth averaging 24.5% over the last eight quarters.
- Peak year-over-year performance for Cash from Operations in the last five years was growth of 154.8% in the quarter ended Dec 31, 2024, against a decline of 63.0% in the quarter ended Dec 31, 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $1.37 billion (quarter ended Mar 31, 2026), $2.43 billion (quarter ended Dec 31, 2025) and $6.56 billion (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 8.62 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 3.44 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 5.37 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 5.88 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 4.58 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 4.00 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 3.57 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 835.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 1.13 Bn |
| 10 | Takeda Pharmaceutical | 2.63 Bn | -23.88 Bn | 5.10 Bn | 800.69 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 800.69 Mn |
| Mar 31, 2026 | 1.37 Bn |
| Dec 31, 2025 | 2.43 Bn |
| Sep 30, 2025 | 6.56 Bn |
| Jun 30, 2025 | 1.49 Bn |
| Mar 31, 2025 | 1.41 Bn |
| Dec 31, 2024 | 2.52 Bn |
| Sep 30, 2024 | 5.60 Bn |
| Jun 30, 2024 | 1.09 Bn |
| Mar 31, 2024 | 1.15 Bn |
| Dec 31, 2023 | 990.78 Mn |
| Sep 30, 2023 | 4.73 Bn |
| Jun 30, 2023 | 674.24 Mn |
| Mar 31, 2023 | 698.54 Mn |
| Dec 31, 2022 | 2.68 Bn |
| Sep 30, 2022 | 5.41 Bn |
| Jun 30, 2022 | 651.38 Mn |
| Mar 31, 2022 | 1.44 Bn |
| Jun 30, 2021 | 1.52 Bn |
| Mar 31, 2021 | 3.79 Bn |
API Access
Takeda Pharmaceutical Cash from Operations API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-operations&ticker=TAK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-operations", "ticker": "TAK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-operations&ticker=TAK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();